While the response to the COVID-19 pandemic has exposed many of the fault lines in the biomedical innovation ecosystem that have slowed progress for decades, we have also shown ourselves capable of innovating in ways we perhaps did not think possible. FasterCures wants to ensure that the lessons of this crisis are not lost when the current urgency subsides—not only for combatting future infectious disease outbreaks but also for conducting every other aspect of biomedical R&D.
In the second half of 2020, informed by over three dozen interviews with key actors involved in the pandemic response from various sectors, we set out to capture the silver linings during the COVID-19 public health emergency, many of which will not remain in place unless collective action is taken. The resulting white paper, “Lessons Learned from COVID-19: Are There Silver Linings for Biomedical Innovation?” identified broad opportunities for focus in the areas of research collaboration, accelerating product development, clinical trial innovation, the collection and use of real-world data and evidence, and addressing racial and ethnic disparities in health care and research.
With input from a working group of external advisors, we built upon the themes that emerged from our white paper to identify specific near-term goals and actions that stakeholders can take to begin to leverage our collective learnings from COVID-19 for the benefit of the whole biomedical research ecosystem—and ultimately for patients suffering from a broad range of deadly and debilitating conditions.
Even before the onset of the COVID-19 pandemic, the United States was confronted with a number of significant policy concerns. Today, working together to solve those challenges is more imperative than ever. The Milken Institute is committed...
Countries undergoing population aging today are facing a much different experience than their historical counterparts. One only needs to look at the countries in Asia to see how these trends are unfolding. Demographic aging is happening...
The 26th annual Milken Institute Global Conference convened the best minds in the world to tackle its most urgent challenges and realize its most exciting opportunities. Throughout the four-day event, our health teams curated nearly three...
Technical Update Dementia presents a pernicious gender-based health disparity in the United States, inflicting a disproportionate burden on women as both patients and caregivers. Given the rapid increase in the population of older Americans...
Nationwide protests in the summer of 2020 sparked many of the largest US corporations to pledge more than $200 billion to advance racial equity and confront the nation’s history of systemic racism. Nonprofits, government agencies, and...
This year’s report, Building a Resilient America: The New Consensus for Action, is part of The Milken Institute-Harris Poll Listening Project, now in its fifth year, which surveys socioeconomic, institutional, and political barriers to...
Employers seek to support their employees while normalizing a whole-person approach to substance use disorders (SUD). The response to addiction and the opioid crisis requires a whole-of-society approach, including employers of all sizes...
The Financial Innovations Labs® and FasterCures teams have collaborated on a project to identify new models for financing the antimicrobial resistant antibiotic pipeline. These past 18 months have demonstrated how consequential public...
While some sounds can be annoying for most people, for a few, certain sounds like chewing, sniffling, or pen clicking can trigger an intense physical and emotional response. Those with this condition can experience increased heart rate...